Results 211 to 220 of about 53,092 (237)

Non-alcoholic Steatohepatitis in Children

Clinics in Liver Disease, 2003
Non-alcoholic steatohepatitis (NASH) is an important liver disease in children; it can cause cirrhosis in children. The disease mechanism involves hepatic insulin resistance with hyperinsulinemia and changes in certain adipocytokines and inflammatory mediators.
openaire   +3 more sources

Statins and non-alcoholic steatohepatitis

Journal of Hepatology, 2016
Vasilios G, Athyros, Niki, Katsiki, Asterios, Karagiannis, Dimitri P, Mikhailidis   +3 more
openaire   +2 more sources

Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis

Journal of Hepatology, 2022
Haoming Zhou, Qingfa Bu, Ling Lu
exaly  

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

Nature Reviews Drug Discovery, 2016
Giovanni Musso, Maurizio Cassader, Roberto Gambino   +2 more
exaly  

How different is the dietary pattern in non-alcoholic steatohepatitis patients?

Clinical Nutrition, 2006
Helena Cortez-Pinto, Henrique Barros, Carla Lopes   +2 more
exaly  

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Lancet, The, 2016
Matthew J Armstrong, Piers Gaunt, Guruprasad P Aithal   +2 more
exaly  

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Lancet, The, 2015
Brent A Neuschwander-Tetri, Joel E Lavine, Mark L Van Natta   +2 more
exaly  

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

Journal of Hepatology, 1999
Herbert L Bonkovsky, Richard W Lambrecht, Barbara F Banner   +2 more
exaly  

Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis

Immunity, 2020
Inés Baba, Philippe Lesnik, Alexandre Boissonnas   +2 more
exaly  

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Lancet, The, 2018
Mary E Rinella, Marcelo Kugelmas, Mustafa R Bashir   +2 more
exaly